Paper19095437
Individual patient data analysis to assess modifications to the RECIST criteria.
Bogaerts J and 9 others. Eur J Cancer, 2009. Cited by 162 papers, by iCite.
Cite this record
ConductScience Library. Individual patient data analysis to assess modifications to the RECIST criteria. Papers, record 19095437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19095437
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Practice Guidelines as Topic | Major topic |
| Statistics as Topic | Major topic |
| Clinical Trials as Topic | |
| Databases, Bibliographic | |
| Disease Progression | |
| Disease-Free Survival | |
| Humans | |
| Medical Records Systems, Computerized | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02448589 | An Investigation of TAS-119 Monotherapy | Background |
Source ClinicalTrials.gov
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588656 | Deep Learning Quality Control for RECIST-Oriented Assessment: A Vision Transformer Predicts Inter-Reader Variability of Unidimensional Lesion Measurements on Contrast CT. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588656 | PubMed |
| 42403716 | Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42403716 | PubMed |
| 40875521 | The legend of the response evaluation criteria in solid tumors: A historical overview. | Cancer | 2025 | https://conductscience.org/library/papers/40875521 | PubMed |
| 40535076 | Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial. | Transl Lung Cancer Res | 2025 | https://conductscience.org/library/papers/40535076 | PubMed |
| 40316348 | A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours. | BMJ Open | 2025 | https://conductscience.org/library/papers/40316348 | PubMed |
| 39576456 | Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA). | Insights Imaging | 2024 | https://conductscience.org/library/papers/39576456 | PubMed |
| 39543673 | A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1). | Cancer Imaging | 2024 | https://conductscience.org/library/papers/39543673 | PubMed |
| 39518034 | The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39518034 | PubMed |
| 39114365 | CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39114365 | PubMed |
| 38779093 | Efficacy of Shenglin decoction in preventing acute severe lymphocytopenia in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy: a study protocol for a randomized controlled trial. | Front Oncol | 2024 | https://conductscience.org/library/papers/38779093 | PubMed |
| 38162847 | Impact of anticancer drugs on the therapeutic efficacy and side effects of hepatic arterial embolization for hepatocellular carcinoma. | JGH Open | 2023 | https://conductscience.org/library/papers/38162847 | PubMed |
| 37881238 | Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor. | Ther Adv Med Oncol | 2023 | https://conductscience.org/library/papers/37881238 | PubMed |
| 37720353 | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology. | Explor Target Antitumor Ther | 2023 | https://conductscience.org/library/papers/37720353 | PubMed |
| 37614659 | Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37614659 | PubMed |
| 37540134 | Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations. | Radiol Imaging Cancer | 2023 | https://conductscience.org/library/papers/37540134 | PubMed |
| 37393537 | The role of clinical imaging in oncology drug development: progress and new challenges. | Br J Radiol | 2023 | https://conductscience.org/library/papers/37393537 | PubMed |
| 37223629 | Lesion Analysis in PERCIST 1.0: Clinical Ease versus Research Requisite-Where Does the Balance Exist? | World J Nucl Med | 2023 | https://conductscience.org/library/papers/37223629 | PubMed |
| 37073741 | Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. | Pediatr Blood Cancer | 2023 | https://conductscience.org/library/papers/37073741 | PubMed |
| 37011149 | FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37011149 | PubMed |
| 36940064 | Multicomponent mathematical model for tumor volume calculation with setup error using single-isocenter stereotactic radiotherapy for multiple brain metastases. | Phys Eng Sci Med | 2023 | https://conductscience.org/library/papers/36940064 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19095437
GET https://conductscience.org/api/papers/v1/19095437/cited_by?page=2